Matthiasson S E, Lindblad B, Bergqvist D
Department of Surgery, Lund University, Malmö General Hospital, Sweden.
Thromb Res. 1994 Jun 15;74(6):655-63. doi: 10.1016/0049-3848(94)90221-6.
An in vivo experimental venous thrombosis model based on endothelial damage and flow reduction was used to investigate the effect of low molecular weight heparin (LMWH) alone and in combination with dextran and the effect of surgical and endothelial trauma on thrombus formation, formation of occlusive thrombi and thrombus weights. Five groups with 15 rabbits in each were studied. Two groups received dalteparin (50 anti-Xa IU/kg i.v.) before surgical trauma or after, during the endothelial trauma and two groups received dalteparin (50 anti-Xa IU/kg i.v.) with dextran 70 (1 g/kg i.v.) before surgical trauma or after, during the endothelial trauma. Compared to a control group (saline) all treatment regimes reduced significantly the frequency of thrombosis and occlusive thrombi as well as thrombus weights. No significant difference was observed between the identical treatment groups when the substances were introduced before respective after surgical trauma. It is concluded, from the present study that thromboprophylaxis with LMWH in this particular in vivo model, given before or after surgical trauma is equally effective. Dextran has a certain augmenting thromboprophylactic effect when added to LMWH in this model.
采用基于内皮损伤和血流减少的体内实验性静脉血栓形成模型,研究低分子量肝素(LMWH)单独使用及与右旋糖酐联合使用的效果,以及手术和内皮创伤对血栓形成、闭塞性血栓形成和血栓重量的影响。研究了五组,每组15只兔子。两组在手术创伤前或后、内皮创伤期间接受达肝素(50抗Xa国际单位/千克静脉注射),两组在手术创伤前或后、内皮创伤期间接受达肝素(50抗Xa国际单位/千克静脉注射)与右旋糖酐70(1克/千克静脉注射)联合使用。与对照组(生理盐水)相比,所有治疗方案均显著降低了血栓形成、闭塞性血栓形成的频率以及血栓重量。当在手术创伤前或后引入这些物质时,相同治疗组之间未观察到显著差异。从本研究得出结论,在这个特定的体内模型中,手术创伤前后给予LMWH进行血栓预防同样有效。在该模型中,右旋糖酐添加到LMWH中具有一定的增强血栓预防作用。